Last reviewed · How we verify
Aselend (SODIUM SELENITE)
Aselend (generic name: SODIUM SELENITE) is a sodium selenite Small molecule drug developed by Fujimoto Pharmaceutical Corporation. It is currently in discontinued development for Hyposelenemia.
Aselend works by providing the body with selenium, an essential mineral that plays a crucial role in various bodily functions.
Aselend is a small molecule compound with the synonyms including Disodium selenite. It is also known as Disodium selenite, Selenious acid disodium salt, and other related names.
At a glance
| Generic name | SODIUM SELENITE |
|---|---|
| Sponsor | Fujimoto Pharmaceutical Corporation |
| Drug class | sodium selenite |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | discontinued |
Mechanism of action
Selenium is an essential mineral that helps protect cells from damage, supports the immune system, and is involved in the production of thyroid hormones. Aselend helps to replenish selenium levels in the body, which can become depleted due to various factors such as poor diet or certain medical conditions. This can help to alleviate symptoms of hyposelenemia and support overall health.
Approved indications
- Hyposelenemia
Common side effects
- Exposure during pregnancy
Key clinical trials
- The Effect of Multiple Micronutrient Supplements in Reducing Anemia in Women of Reproductive Age (NA)
- Healthy Mums, Healthy Babies: Multiple Micronutrient Supplementation in Ethiopia
- Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer (PHASE1)
- The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED) (PHASE2,PHASE3)
- Sodium Selenite Supplementation in Patients With Head and Neck Cancer (NA)
- High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy (PHASE3)
- An Exploratory Investigation of a Supplement to Promote Cognitive Health Benefits (NA)
- Selenium for Musculoskeletal Health (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aselend CI brief — competitive landscape report
- Aselend updates RSS · CI watch RSS
- Fujimoto Pharmaceutical Corporation portfolio CI
Frequently asked questions about Aselend
What is Aselend?
How does Aselend work?
What is Aselend used for?
Who makes Aselend?
What is the generic name of Aselend?
What drug class is Aselend in?
What development phase is Aselend in?
What are the side effects of Aselend?
Related
- Drug class: All sodium selenite drugs
- Manufacturer: Fujimoto Pharmaceutical Corporation — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Hyposelenemia
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing